AIM: 18F-FDG-PET (FDG-PET) is established in staging and follow-up of malignant melanoma. The legs are affected in 1040% at time of diagnosis even if the primary is at the arms and torso...
Keywords: FDG-PET, malignes Melanom, Ganglion, Dermatofibrom
01/2003 | Nuklearmedizin, SchattauerPatients with coronary artery disease who undergo FDG, PET for therapy monitoring after intracoronary progenitor cell infusion (PCT) show an increased bone marrow uptake in some cases...
Keywords: FDG-PET, Knochenmark-Uptake, Progenitorzelltherapie, G-CSF
01/2005 | Nuklearmedizin, SchattauerSquamous cell oesophageal carcinoma is the most common carcinoma of the oesophagus worldwide. The tumour stage as most important prognostic factor determines the clinical management...
Keywords: Plattenepithelkarzinom, Ösophaguskarzinom, Staging, FDG-PET, Metastasierung
01/2006 | Nuklearmedizin, SchattauerAIM: The intraarterial chemotherapy (i.a.CHT) using high dose cisplatin combined with systemic neutralization in patients with head and neck cancer (HNSCC) is used to reduce the tumor volume preoperatively...
Keywords: FDG-PET, Plattenepithelkarzinom der Kopf-Hals-Region, intraarterielle Chemotherapie, zervikale Lymphknoten, zervikale Lymphknotenmetastasen, standardisierter Uptake-Wert
01/2006 | Nuklearmedizin, Schattauer